Episode 8: The Changing Treatment Paradigm of HER2+ Metastatic Breast Cancer

SABCS 2021: Combination Strategies Under Investigation for R/R HER2+ mBC

Considering data from the SABCS 2021 annual meeting, Dr. VK Gadi and experts discuss novel combination strategies for relapsed/refractory HER2+ metastatic breast cancer.

The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.

Translate »